CME Group IncFind Ratings Reports
CME GROUP INC's gross profit margin for the third quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income during the past quarter when compared with the same quarter a year ago, however, it was unable to keep up with the growth of the average competitor within its industry. CME GROUP INC has very weak liquidity. Currently, the Quick Ratio is 0.06 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has remained unchanged from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY16||Q3 FY15|
|Net Sales ($mil)||879.9||852.8|
|Net Income ($mil)||472.8||359.9|
|Balance Sheet||Q3 FY16||Q3 FY15|
|Cash & Equiv. ($mil)||1533.3||1538.7|
|Total Assets ($mil)||63251.3||80949.6|
|Total Debt ($mil)||2230.7||2241.2|
|Profitability||Q3 FY16||Q3 FY15|
|Gross Profit Margin||70.31||69.31|
|Return on Assets||2.29||1.55|
|Return on Equity||6.83||5.9|
|Debt||Q3 FY16||Q3 FY15|
|Share Data||Q3 FY16||Q3 FY15|
|Shares outstanding (mil)||337.98||336.74|
|Div / share||0.6||0.5|
|Book value / share||62.92||63.48|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1755763.0||1245893.0|
BUY. The current P/E ratio indicates a premium compared to an average of 23.30 for the Capital Markets industry and a value on par with the S&P 500 average of 25.46. To use another comparison, its price-to-book ratio of 1.84 indicates a discount versus the S&P 500 average of 2.84 and a significant discount versus the industry average of 4.30. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. The valuation analysis reveals that, CME GROUP INC seems to be trading at a premium to investment alternatives within the industry.
|CME 26.97||Peers 23.30||CME 24.74||Peers 16.17|
Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.
CME is trading at a premium to its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CME is trading at a significant premium to its peers.
|CME 24.67||Peers 34.30||CME 1.44||Peers 2.04|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
CME is trading at a discount to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CME trades at a significant discount to its peers.
|CME 1.84||Peers 4.30||CME 15.01||Peers 41.89|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CME is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CME is expected to significantly trail its peers on the basis of its earnings growth rate.
|CME 10.93||Peers 7.04||CME 5.46||Peers 2.38|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CME is trading at a significant premium to its industry.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
CME has a sales growth rate that significantly exceeds its peers.